Santosh Vetticaden ready for Adventrx as CMO
This article was originally published in Scrip
Executive Summary
Biopharmaceutical company Adventrx Pharmaceuticals has appointed Dr Santosh Vetticaden chief medical officer and senior vice-president. Dr Vetticaden most recently served as senior vice-president and chief medical and development officer at Cubist Pharmaceuticals.